Why Option Care Health Stock Skyrocketed on Tuesday

Axe Cap view

McKesson-Backed Buyout Lifts Option Care Health Sharply

Option Care Health surges 33% after agreeing to a $5.8bn take-private deal led by McKesson and private equity.

The announcement that McKesson and Clayton, Dubilier & Rice will acquire Option Care Health at a hefty 37% premium jolted the stock higher on Tuesday. While this deal highlights the growing importance of home infusion services in healthcare, it’s a tale mostly relevant to US markets. For South African investors, the impact is indirect but real. Such deals often boost demand for offshore dollars, which could tighten USD/ZAR especially if other emerging market flows slow. Domestically, Rand strength always pressures exporters and resource plays. Among local stocks, banks like Standard Bank and FirstRand could face shifting capital flows as investors rebalance toward or away from offshore holdings. Still, this move is not a green light to pile into US healthcare stocks or Rand carry trades. The global healthcare space is undergoing rapid consolidation, but the Rand’s path will largely hinge on local factors. If the USD finds renewed safe haven demand, expect USD/ZAR to test higher again, something SA traders should watch carefully. this is just our opinion and not financial advice